LONDON, UK — 18th November 2024, Live from ISPOR Europe in Barcelona, Access Infinity is delighted to announce the launch of Evidence Hub an AI-powered evidence management solution specifically designed to transform how HEOR, value, and access teams manage evidence. This innovative platform is set to solve the most common challenges in evidence management by offering an intuitive, centralised, and future-proof solution.
Evidence Hub is built to address the key pain points that cross-functional teams face when dealing with disparate and static repositories of evidence. Traditional tools such as Excel or SharePoint are no longer sufficient for managing vast amounts of data and evidence in today’s dynamic, fast-paced environments. Evidence Hub empowers teams by saving time, enhancing governance, and making it easy for users to find the right evidence at the right time.
Commenting on the launch of Evidence Hub, Keshav Nagaraja, Managing Director – Digital, at Access Infinity said:
The Access Infinity team is showcasing Evidence Hub throughout this year’s ISPOR Europe in Barcelona, Spain from 18th – 20th November. To find out more and see the solution in action, visit the team at Booth 800.
Related resources:
For more information about Evidence Hub, please visit: accessinfinity.com/evidence-hub
To hear more about how Evidence Hub is transforming evidence management with AI, watch the on-demand webinar: accessinfinity.com/webinar/transforming-evidence-management-with-ai
Founded in 2014, Access Infinity exists to help pharma companies overcome market access challenges. The company began as a consulting firm to guide pharma businesses in developing and implementing effective market access and pricing strategies and continues to be a leader in the space. It has since introduced market-redefining digital tools, NUROTM, Access HubTM and Evidence Hub to help market access teams work smarter, faster, and more efficiently with valuable insights at their fingertips.
With offices in London, Hyderabad, New York and Manchester, Access Infinity is experiencing rapid growth as it continues to transform and simplify market access for pharmaceutical organisations globally. Clients include many of the pharmaceutical industry’s most influential companies such as AstraZeneca, J&J, MSD, GSK and Pfizer. In 2023 Access Infinity received a Bronze Stevie® Award in the Technical Innovation of the Year category for organisations with up to 100 employees. The business was also recognised in GHP magazine’s Healthcare & Pharmaceutical Awards, winning “Most innovative digital pharmaceuticals platform 2023 UK”.
For media enquiries, please contact:
Email: louise@accessinfinity.com
Tel: +44 (0)2027 0787643